sur NOVACYT (EPA:ALNOV)
Novacyt Announces HY 2024 Results and Investor Webinar
Novacyt S.A., listed on Euronext Growth and AIM, will release its unaudited financial results for the first half of 2024 on 26 September 2024. The molecular diagnostics company emphasizes its integrated technologies and services across various sectors.
On the same day, Novacyt's CEO, Lyn Rees, and CFO, Steve Gibson, will host an investor webinar at 11:00am BST. The webinar includes a presentation and Q&A session via the Investor Meet Company platform. Current and potential investors are invited to participate, with questions accepted until 9.00am the previous day or during the live event.
Investors can register for the webinar online. Those already following Novacyt on the platform will receive an automatic invitation. Novacyt focuses on diagnostic technologies in human, animal, and environmental health, offering tools like PCR machines and DNA sample preparation platforms.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de NOVACYT